Capio Citykliniken Hjartmottagning

Lund 22221

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Chronic Heart Failure With Reduced Ejection Fraction, Hyperlipidemia

Studies at this site

• A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early